Thrombectomy Devices Market - Emerging Markets Offers High Growth Opportunities
According to research report the global thrombectomy
devices market is estimated to reach USD 1.45 billion by 2022; growing at a
CAGR of 6.7% during the forecast period.
Over the last few years, the thrombectomy devices market
has witnessed significant advancements in terms
of the product development and commercialization. The major factors
driving the growth of the market are growing target patient population, ongoing
technological advancements in thrombectomy devices, favorable medical
reimbursement scenario, rising demand for minimally invasive thrombectomy
procedures, and increasing healthcare expenditure across emerging markets.
In this report, the market has been segmented by type, application, end user, and region.
In 2016, North America held the largest share of the market.
However, the developing Asia-Pacific countries including China and India are expected
to emerge as the new revenue-generating regions for prominent market players
during 2017-2022. The growth of this Asia-Pacific market is attributed to the presence of a large patient
population for target diseases, rising awareness among surgeons related to the
benefits offered by thrombectomy devices, increasing healthcare expenditure,
and rising adoption of these devices due to their decreasing costs.
Based on type, the
market is segmented into aspiration, mechanical, rheolytic, and ultrasonic
thrombectomy devices. The ultrasonic thrombectomy devices segment is poised to
be the fastest growing during the forecast period. The growing demand for ultrasonic
thrombectomy devices can primarily be attributed
to factors such as rising adoption of ultrasonic thrombectomy products by
medical professionals, higher therapeutic efficacy for the treatment of deep
vein thrombosis and pulmonary embolism, and its affordability.
On the basis of application, the market is segmented into
cardiovascular, neurovascular, and peripheral vascular applications. Peripheral
vascular segment is expected to be the fastest growing in the market during the
forecast period. This growth can be attributed
to the rising availability of medical reimbursements for peripheral
thrombectomy procedures across major markets, rising incidence of vascular
disorders across the globe, growing geriatric population, ongoing technological
advancements in the field of vascular ultrasound treatment, and rising awareness related to clinical efficacy of thrombectomy procedures in
PVD treatment.
Get Report Sample:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=222966801
By end user, the market is segmented into hospitals &
surgical centers, ambulatory surgical centers, research laboratories & academic
institutes, and other end users. Ambulatory surgical centers (ASCs) are
expected to be the fastest growing end user
segment in the market. This high growth can be
attributed to the increasing availability of reimbursement for
thrombectomy procedures in outpatient settings, ongoing advancements in
minimally invasive surgical techniques, increasing number of image-guided
surgeries performed at ASCs, and rising market demand for miniaturized
therapeutic devices.
Comments
Post a Comment